Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600115970) titled 'Effects of Different Doses of Nalbuphine on Sevoflurane MAC during Cervical Dilation in Patients Undergoing Hysteroscopic Surgery' on Jan. 4.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Guangyuan Central Hospital
Condition:
Hysteroscopic Surgery
Intervention:
Group N1:Nalbuphine 0.1 mg/kg was administered intravenously prior to anesthesia induction.
Group N2:Nalbuphine 0.2 mg/kg was administered intravenously prior to anesthesia induction.
Group N3:Nalbuphine 0.4 mg/kg was administered intravenously prior to anesthesia induction.
Recruitment Status: Not Recruiting
Phase: 4 ...